Announcements Trials
Browse Landscape

Status

Withdrawn 2Completed 2No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Breast 1

Conditions

Metastatic gpNMB Expressing Triple Negative Breast Cancer 1

Interventions

veliparib 2tucatinib 1pegilodecakin 1palbociclib 1leronlimab 1iniparib 1glembatumumab vedotin 1Vinorelbine 1Letrozole 1Everolimus 1Cisplatin 1Alpelisib 1Ado-Trastuzumab Emtansine 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × glembatumumab vedotin × Breast × Clear all
NCT03067935 2018-05-21

Individual Patient Expanded Access-Glembatumumab Vedotin

Celldex Therapeutics

No longer available
Breast

Metastatic gpNMB Expressing Triple Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡